MIAMI, FL / ACCESSWIRE / March 31, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. VVUS, COOL, SKYS, and GNCA have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the Nasdaq/NYSE subscribe to our newsletter at TopNasdaqStocks.com.

VIVUS Inc. (NASDAQ: VVUS) is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity and sexual health. In its press release regarding 2015 annual and fourth quarter results, Seth H. Z. Fischer, VIVUS Chief Executive Officer, stated, "]We have been pleased with the interest we have received for STENDRA® since announcing the return of the U.S. and Canadian commercialization rights in December 2015?We have initiated a process with a strategic advisor to assist us in evaluating not only our STENDRA alternatives, but our overall business strategy as well."

Since March 24 the stock is up more than 30% from lows of nearly $1 to highs of $1.375 on Thursday (3/31).

Stay Informed and Up To Date On The Hottest NASDAQ Plays. Get Them Here

Majesco Entertainment Co. (NASDAQ:COOL) has seen an increase in volume and price since March 21st. The stock has seen highs of nearly $1 and volume as high as 464,400 shares in a single day as compared to previous weeks where average volume was roughly 10,000 shares per day with price between $0.73 and $0.82. On March 22 the company announced the launch of its new game, Glue, for PC. Barry Honig, Co-Chairman and Chief Executive Officer, commented: "We are excited about launching Glue for the PC. The company has spent significant time developing the game and we believe it will be a great success in the market."

Subscribe Now And Reserve A Spot To Receive Our First Alert Of April. Get Your Free Membership Now.

Sky Solar Holdings, Ltd. (NASDAQ: SKYS) recorded Q4 2015 total revenue of $12.2 million, up 49% over Q4 2014. The company also reported Q4 2015 electricity revenue of $7.9 million, up 127% over Q4 2014. Since making the announcement, the company's stock has increased from lows on Wednesday (3/30) of $1.12 to highs on Thursday 3/31 of $2.56 before noon. This represents a total move of 128.6% in less than 48 hours.

Enjoy picks like this? Get These Alerts and More on NASDAQ Companies before They Rally, Text the word "NASDAQ" to 77948

Genocea Biosciences, Inc. (NASDAQ: GNCA) announced on Thursday (3/31) that it had received positive 12 month efficacy data from its Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. "These 12 month data highlight the potential of GEN-003 to significantly enhance the genital herpes treatment landscape," said Lori A. Panther, M.D., MPH. The stock has seen a jump of more than 40% from its previous close after making this announcement.

Stay Informed and Up To Date On The Hottest NASDAQ Plays. Get Them Here.

About TopNasdaqStocks.com

Looking for stock market and business news headlines? How about up to the minute information on mutual funds and ETFs? Don't forget about the top stock picks of 2016. TopNasdaqStocks.com has it all. Make sure to subscribe to our free newsletter and to receive free text message alerts on your phone, text "NASDAQ" to 77948.

Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor's or other person's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. Pursuant to an agreement between us and a non affiliate 3rd party we were hired for a period beginning on 3/20/16 and ending on 6/19/16 to publicly disseminate information about (cool) including on the website and other media including facebook and twitter. We are being paid $100,000 (cash) for or were paid "zero" shares of unrestricted or restricted common shares. We own zero shares of (cool), which we purchased in the open market. We plan to sell the "zero" shares of (cool) that we hold during the time the website and/or facebook and twitter information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (cool) in the open market at any time, including before, during or after the website and information, provide public dissemination of favorable information. Top Nasdaq Stocks has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding SKYS, GNCA, or VVUS in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words "anticipate," "intend," "estimate," "believe," "expect," "plans," "should," "potential," "forecast," and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company's actual results could differ materially from those described in any forward-looking statements contained herein. Top Nasdaq Stocks is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit http://topnasdaqstocks.com/index.php/disclaimer/ website for a more detailed discussion of risks and disclosures.

Contact:

Top Nasdaq Stocks
news@topnasdaqstocks.com

SOURCE: Top Nasdaq Stocks